Tune in for Motley Fool Advisor Karl Thiel’s debut on Industry Focus as our resident biotech expert discusses the advances and challenges of CRISPR gene-editing technology, as well as how investors should be thinking about the space.
Check out more of our content here:
Podcasts)
Youtube)
Twitter)
Reach us by Email @ [email protected])
